Influence of Physician Specialty on Treatment Recommendations in the Multidisciplinary Management of Soft Tissue Sarcoma of the Extremities
Open Access
- 1 July 2013
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Surgery
- Vol. 148 (7) , 632-639
Abstract
The contemporary management of soft tissue sarcoma (STS) of the extremities requires coordinated multimodality treatment strategies involving several specialties in a multidisciplinary setting. For localized disease, surgical resection is the cornerstone of curative-intent therapy and, with the addition of radiation therapy, has been crucial in establishing limb-sparing surgery as the standard of care. This approach was validated in seminal randomized trials demonstrating equivalent survival outcomes between amputation and conservative limb-sparing surgery combined with radiation therapy.1,2Keywords
This publication has 12 references indexed in Scilit:
- The Treatment of Soft-Tissue Sarcomas of the Extremities. Prospective Randomized Evaluations of (1) Limb-Sparing Surgery Plus Radiation Therapy Compared with Amputation and (2) the Role of Adjuvant Chemotherapy2013
- Influence of Specialty and Clinical Experience on Treatment Sequencing in the Multimodal Management of Soft Tissue Extremity SarcomaAnnals of Surgical Oncology, 2011
- Survey of ASCO Members on Management of Sentinel Node Micrometastases in Breast Cancer: Variation in Treatment Recommendations According to SpecialtyAnnals of Surgical Oncology, 2009
- A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcomaCancer, 2008
- The Role of Radiation Therapy in the Management of SarcomasSurgical Clinics of North America, 2008
- Racial and ethnic differences in treatment and survival among adults with primary extremity soft‐tissue sarcomaCancer, 2008
- Adjuvant Chemotherapy for Adult Soft Tissue Sarcomas of the Extremities and Girdles: Results of the Italian Randomized Cooperative TrialJournal of Clinical Oncology, 2001
- Randomized Phase III Study Comparing Conventional-Dose Doxorubicin Plus Ifosfamide Versus High-Dose Doxorubicin Plus Ifosfamide Plus Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Soft Tissue Sarcomas: A Trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma GroupJournal of Clinical Oncology, 2000
- Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.Journal of Clinical Oncology, 1998
- Socioeconomic status and survival from soft-tissue sarcomas: a population-based study in northern Italy.American Journal of Public Health, 1991